{"id":117590,"date":"2012-08-31T00:00:00","date_gmt":"2012-08-31T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/report\/hpwpexecutivebriefing0812_5-marketaccess-executive-briefing-the-affordable-care-act-a\/"},"modified":"2012-08-31T00:00:00","modified_gmt":"2012-08-31T00:00:00","slug":"hpwpexecutivebriefing0812_5-marketaccess-executive-briefing-the-affordable-care-act-a","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/hpwpexecutivebriefing0812_5-marketaccess-executive-briefing-the-affordable-care-act-a\/","title":{"rendered":"Executive Briefing | The Affordable Care Act: a prescription for expanded PBM influence | August 2012"},"content":{"rendered":"<p>HealthLeaders-InterStudy has prepared an executive briefing.<\/p>\n","protected":false},"template":"","class_list":["post-117590","report","type-report","status-publish","hentry","report-gateway-marketaccess","marketaccess-date-570"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/117590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/117590\/revisions"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=117590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}